QA: Larimar Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001374690_2023_Larimar_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001374690, Larimar Therapeutics Inc.

  xvar xval
0 AssetsCurrent 120,739,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 831,000
3 remainder_Assets 4,835,000
4 LiabilitiesCurrent 10,705,000
5 LiabilitiesNoncurrent 4,797,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,276,000
9 ResearchAndDevelopmentExpense 24,250,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,171,000
13 remainder_ComprehensiveNetIncome -31,000
  yvar yval
0 Assets 126,405,000
1 Liabilities 15,502,000
2 Expenses 36,526,000
3 Revenues 0
4 StockholdersEquity 110,903,000
5 NetIncome -35,355,000
6 ComprehensiveNetIncome -35,370,500
7 BaseVar 89,817,500
8 EconomicCapitalRatio 2.19

Edgar->Model Mapping

Feature Distribution

Change over Time